NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
Voltar para busca
Dado oficial do USPTO
NURTUR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
15/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
08/02/2016
Data de registro
30/05/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/12/2023
Última transação
15/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
DK
Examinador
CUCCIAS, MATTHEW JAMES
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
GLYCOM A/S
Representantes
Stephanie L. Crigler Dinsmore & Shohl LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Human milk oligosaccharide (HMO) preparations for use in industry and as raw material in the manufacture of other goods and other than for medical use; human milk oligosaccharide (HMO) additives for use in the manufacture of pharmaceuticalsnutraceuticalsinfant formulafoodstuffs; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for the food industry; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for scientific useother than for medical or veterinary use; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for industrial use; human milk oligosaccharide compoundschemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for use in the manufacture of pharmaceuticalsnutraceuticalsinfant formulafoodstuffs; chemicals for use as a supplement in the preparation of dietary supplements and infant formula
Classe 5
Dietetic food and substanceshuman milk oligosaccharide adapted for medical usefood for babies and infant formula; dietary supplements for humans; medicated food additives in the nature of dietary supplements containing human milk oligosaccharide for humans; medicated preparations for use as additives for food for human consumptionhuman milk oligosaccharide for medical or veterinary purposesvitamin preparations for use as a supplement for dietary supplements and infant formula; food supplements for dietetic use; dietary supplements for medical use; medicated supplements for foodstuffs for humansincluding for infants; mineral food supplements; colostrum supplements; dietary supplemental drinks and nutritionally fortified beverages for medical purposes; dietary supplements for infants; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds for medical purposes; human milk oligosaccharide additives being dietary and nutritional supplements for use in connection with pharmaceuticalsnutraceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
14/09/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
28/08/2024
INPC
INVALIDATION PROCESSED
28/08/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
16/08/2024
C71T
CANCELLED SECTION 71
15/12/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/05/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/04/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/01/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/01/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/09/2017
FIMP
FINAL DISPOSITION PROCESSED
06/09/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/08/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
24/08/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
30/05/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
21/04/2017
CHPB
POST PUBLICATION AMENDMENT - ENTERED
08/04/2017
APET
ASSIGNED TO PETITION STAFF
31/03/2017
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/03/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
29/12/2016
PUBO
PUBLISHED FOR OPPOSITION
06/12/2016
NPUB
NOTICE OF PUBLICATION
16/11/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/11/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/10/2016
CNEA
EXAMINERS AMENDMENT MAILED
27/10/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
26/10/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/10/2016
CNFR
FINAL REFUSAL MAILED
26/10/2016
CNFR
FINAL REFUSAL WRITTEN
25/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2016
ALIE
ASSIGNED TO LIE
29/09/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/09/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/09/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/09/2016
RFNT
REFUSAL PROCESSED BY IB
24/06/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/06/2016
RFRR
REFUSAL PROCESSED BY MPU
07/06/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/06/2016
CNRT
NON-FINAL ACTION WRITTEN
06/06/2016
MAFR
APPLICATION FILING RECEIPT MAILED
04/06/2016
DOCK
ASSIGNED TO EXAMINER
31/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/05/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
27/05/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NURTUR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.